The splenocyte proliferative response and cytokine secretion in mice after oral administration of commercial gold nanocolloid

• Autorzy: Malaczewska J.
• Języki publikacji: EN

Abstrakty

EN

Owing to their unique physicochemical properties, gold nanoparticles find numerous biomedical applications. Experiments on rodents prove that the main target organs of gold nanoparticles entering an organism are the liver and spleen, whose reticuloendothelial system removes foreign particles from the bloodstream. Through interactions with resident tissue macrophages, nanoparticles can evoke a systemic immunological response. The aim of this study has been to determine the effect of oral administration of commercial gold nanocolloid, recommended by the producer inter alia as a dietary supplement, on the proliferative activity and cytokine secretion by murine splenocytes. The colloid was given to the animals in three different doses (0.25, 2.5, 25 ppm), for three different time periods (7, 14, 28 days). The influence of nanogold on splenocyte functions was time-dependent and the various doses were distinguished by distinct modes of action. The lowest dose had a pro-inflammatory or immunostimulating effect, enhancing the synthesis of pro-inflammatory cytokines (IL-1ß, IL-6, TNF-a). The effect of the highest dose can be considered as a pro-inflammatory, or immunotoxic one, because the stimulated cytokine synthesis was accompanied by a drastic decline in the proliferative activity of lymphocytes. The medium dose, while inhibiting the synthesis of pro-inflammatory cytokines of macrophages, simultaneously stimulated the proliferation of lymphocytes. All the doses also modulated the synthesis of IL-2, which may implicate their effect on the immunoregulatory mechanisms of an organism. The effect of alimentary administration of gold nanocolloid on the immune system seems to be difficult to predict, hence a risk that this type of dietary supplements might have some adverse impact on the immunity cannot be excluded, especially after their chronic administration.

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2015
• Tom: 18
• Numer: 1
• Opis fizyczny: p.181-189,ref.

Twórcy

autor

Malaczewska J.

• Department of Microbiology and Clinical Immunology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-718 Olsztyn, Poland

Bibliografia

• Chen H, Dorrigan A, Saad S, Hare DJ, Cortie MB, Valen-zuela SM (2013) In vivo study of spherical gold nanoparticles: inflammatory effects and distribution in mice. PLoS One 8: e58208.
• De Jong WH, Van Loveren H (2007) Screening of xenobiotics for direct immunotoxicity in an animal study. Methods 41: 3-8.
• Dokić J, Rudolf R, Tomić S, Stopić S, Friedrich B, Budic B, Anzel I, Colić M (2012) Immunomodulatory properties of nanoparticles obtained by ultrasonic spray pyrolysis from gold scrap. J Biomed Nanotechnol 8: 528-538.
• Dykman LA, Sumaroka MV, Staroverov SA, Zaitseva IS, Bogatyrev VA (2004) Immunogenic properties of the colloidal gold. Izv Akad Nauk Ser Biol 1: 86-91.
• Farkas J, Christian P, Urrea JA, Roos N, Hassellv M, Tollef-sen KE, Thomas KV (2010) Effects of silver and gold nanoparticles on rainbow trout (Oncorhynchus mykiss) hepatocytes. Aquat Toxicol 96: 44-52.
• Gerber A, Bundschuh M, Klingelhofer D, Groneberg DA (2013) Gold nanoparticles: recent aspects for human toxicology. J Occup Med Toxicol 8: 32.
• Hillyer JF, Albrecht RM (2001) Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 90: 1927-1936.
• Hoyer KK, Dooms H, Barron L, Abbas AK (2008) Inter-leukin-2 in the development and control of inflammatory disease. Immunol Rev 226: 19-28.
• Lan RY, Selmi C, Gershwin ME (2008) The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2). J Autoimmun 31: 7-12.
• Lasagna-Reeves C, Gonzales-Romero D, Barria MA, Olmedo I, Clos A, Sadagopa Ramanujam VM, Urayama A, Vergara L, Kogan MJ, Soto C (2010) Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun 393: 649-655.
• Lee JY, Park W, Yi DK (2012) Immunostimulatory effects of gold nanorod and silica-coated gold nanorod on RAW 264.7 mouse macrophages. Toxicol Lett 209: 51-57.
• Małaczewska J (2014) The in vitro effect of commercially available noble metal nanocolloids on the splenocyte pro-liferative response and cytokine production in mice. Pol J Vet Sci 17: 37-45.
• Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
• Muraguchi A, Kehrl JH, Longo DL, Volkman DJ, Smith KA, Fauci AS (1985) Interleukin 2 receptors on human B cells . Implications for the role of interleukin 2 in human B cell function. J Exp Med 161: 181-197.
• Pedersen MO, Larsen A, Pedersen DS, Stoltenberg M, Penkowa M (2009) Metallic gold reduces TNF alpha expression, oxidative DNA damage and pro-apoptotic signals after experimental brain injury. Brain Res 1271: 103-113.
• Pereira DV, Petronilho F, Pereira HR, Vuolo F, Mina F, Possato JC, Vitto MF, de Souza DR, da Silva L, da Silva Paula MM, de Souza CT, Dal-Pizzol F (2012) Effects of gold nanoparticles on endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci 53: 8036-8041.
• Pissuwan D, Kumagai Y, Smith NI (2013) Effect of surface-modified gold nanorods on the inflammatory cytokine response in macrophage cells. Part Part Syst Charact 30: 427-433.
• Sad S, Mosmann TR (1994) Single IL-2-secreting, precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J Immunol 153: 3514-3522.
• Sharma M, Salisbury RL, Maurer EI, Hussain SM, Sulentic CE (2013) Gold nanoparticles induce transcriptional activity of NF-kB in a B-lymphocyte cell line. Nanoscale 5: 3747-3756.
• Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry M (2005) Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 21: 10644-10654.
• Sonavane G, Tomoda K, Makino K (2008) Biodistribution of colloidal gold nanoparticles after intavenous administration: effect of particle size. Colloids Surf B Biointerfaces 66: 274-280.
• Sumbayev VV, Yasinska IM, Garcia CP, Gilliland D, Lall GS, Gibbs BF, Bonsall DR, Varani L, Rossi F, Calzolai L (2013) Gold nanoparticles downregulate interleukin-1 ß-induced pro-inflammatory responses. Small 9: 472-477.
• Sung JH, Ji JH, Park JD, Song MY, Song KS, Ryu HR, Yoon JU, Jeon KS, Jeong J, Han BS, Chung YH, Chang HK, Lee JH, Kim DW, Kelman BJ, Yu IJ (2011) Subchronic inhalation toxicity of gold nanoparticles. Part Fibre Toxicol 8: 16.
• Thakor AS, Jokerst J, Zavaleta C, Massoud TF, Gambhir SS (2011) Gold nanoparticles: a revival in precious metal administration to patients. Nano Lett 11: 4029-4036.
• Tsai CY, Lu SL, Hu CW, Yeh CS, Lee GB, Lei HY (2012) Size-dependent attenuation of TLR9 signaling by gold nanoparticles in macrophages. J Immunol 188: 68-76.
• Tsai CY, Shiau AL, Chen SY, Chen YH, Cheng PC, Chang MY, Chen DH, Chou CH, Wang CR, Wu CL (2007) Amelioration of collagen-induced arthritis in rats by nanogold. Arthritis Rheum 56: 544-554.
• Yang L, Mosmann T (2004) Synthesis of several chemokines but few cytokines by primed uncommitted precursor CD4 T cells suggests that these cells recruit other immune cells without exerting direct effector functions. Eur J Immunol 34: 1617-1626.
• Yen HJ, Hsu SH, Tsai CL (2009) Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small 5: 1553-1561.
• Zhang Q, Hitchins VM, Schrand AM, Hussain SM, Goering PL (2011) Uptake of gold nanoparticles in murine macrophage cells without cytotoxicity or production of pro-inflammatory mediators. Nanotoxicology 5: 284-295.
• Zhang XD, Wu HY, Wu D, Wang YY, Chang JH, Zhai ZB, Meng AM, Liu PX, Zhang LA, Fan FY (2010) Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int J Nanomedicine 5: 771-781.

Identyfikatory

DOI

10.1515/pjvs-2015-002